MYELOMA MINUTE | Up To The Minute News | 12.16.2021 |
|
|
 |
Tips for Building and Maintaining Our Resilience in the New Year |
Small actions can make a big difference in our well-being, says IMF Chairman Dr. Brian G.M. Durie. He recommends small doses of exercise, meditation and, of course, silly videos for nourishing our resilience as we head into 2022. |
|
 |
Don’t Miss the Best of ASH 2021 Webinar Today! |
Today at 4 p.m. PST; 5 p.m. MT; 6 p.m. CT; and 7 p.m. EST, Dr. Brian G.M. Durie will discuss important takeaways relating to multiple myeloma from this year’s American Society of Hematology (ASH) conference. Get to know the highlights of the top myeloma abstracts that were presented at the ASH annual conference in this “Best of ASH 2021” webinar. |
|
 |
Support Group Leaders Attended the 2021 ASH Meeting. Read Their Blogs. |
The International Myeloma Foundation (IMF) brought together myeloma support group leaders and patients to this year’s virtual 63rd Annual Meeting and Exposition of the American Society of Hematology (ASH). The 63rd ASH meeting was an exciting convergence of 20,000 healthcare professionals from across the globe. Read through the IMF ASH team members’ accounts of the event via their blogs. |
|
 |
Watch the Replay: The IMWG Conference Series |
Watch the replay of this lively discussion on the forefront of the future of myeloma research and care — moderated by IMF Chairman of the Board Dr. Brian G.M. Durie. Leading myeloma experts discuss the latest drug therapy from ASH 2021, and focus on other highlights from the 879 multiple-myeloma-related abstracts from the ASH conference this year. |
|
 |
Shop for a Cause with this Member FUNraiser: Laurie’s Winter Hat Boutique |
Explore and shop at Laurie’s Winter Hat Boutique for hand-knit hats to keep you warm during these chilly winter days and to raise money for a cause! All proceeds will go to myeloma research with the International Myeloma Foundation. |
|
 |
#ASKDRDURIE | Dr. Durie's Weekly Web Video Series |
This Week’s Question:
Are MGUS patients at higher risk of getting severely ill from COVID-19? |
|
|
|
|
We Thank Our Sponsors:
|
Amgen, Bristol Myers Squibb, GSK, Karyopharm Therapeutics, Oncopeptides Inc., Sanofi-Genzyme, and Takeda Oncology |
We also thank individuals like you for your continued support! |
|
Join the conversation at The International Myeloma Foundation |
Facebook: /Myeloma | Twitter @IMFMyeloma | Instagram @IMFmyeloma
www.myeloma.org |
This email was sent by: The International Myeloma Foundation 4400 Coldwater Canyon Ave., Suite 300 Studio City, CA 91604 Connect with the IMF InfoLine 1-800-452-2873 |
We respect your privacy and your preferences for communications of this nature. Home • Unsubscribe • Privacy Policy |
View as web page |